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Abstract
Background: Published prevalence studies on multimorbidity present diverse data collection methods, sources of 
data, targeted age groups, diagnoses considered and study populations, making the comparability of prevalence 
estimates questionable. The objective of this study was to compare prevalence estimates of multimorbidity derived 
from two sources and to examine the impact of the number of diagnoses considered in the measurement of 
multimorbidity.
Methods: Prevalence of multimorbidity was estimated in adults over 25 years of age from two separate Canadian 
studies: a 2005 survey of 26,000 respondents randomly selected from the general population and a 2003 study of 980 
patients from 21 family practices. We estimated the prevalence of multimorbidity based on the co-occurrence of ≥ 2 
and ≥ 3 diseases of the seven diseases listed in the general population survey. For primary care patients, we also 
estimated multimorbidity prevalence using an open list of chronic diseases.
Results: Prevalence estimates were considerably higher for each age group in the primary care sample than in the 
general population. For primary care patients, the number of chronic diseases considered for estimates resulted in 
large differences, especially in younger age groups. The prevalence of multimorbidity increased with age in both study 
populations.
Conclusions: The prevalence of multimorbidity was substantially lower when estimated in a general population than 
in a family practice-based sample and was higher when the number of conditions considered increased.
Background
As a result of different factors, including aging popula-
tions and advances in medical care and public health pol-
icy, a growing proportion of patients present multiple
coexistent diseases, or multimorbidity [1]. To estimate
the magnitude of this problem, studies about the preva-
lence of multimorbidity have been conducted in different
parts of the world: in Europe [1-5], the Middle East [6],
Australia [7], the United States [8-10], and Canada [11-
13]. These studies present diverse sources of data (e.g.,
questionnaires, chart reviews, administrative data), data
collection methods, targeted age groups, diagnoses con-
sidered and study populations, making the comparability
of prevalence estimates questionable. Some studies
[5,6,8-11] focused on data from samples of the general
population; others [1-3,7,13] from primary care practices.
In a recent study [4] on the prevalence of multimorbidity
in four different settings (population-based, general prac-
tice, hospital and nursing home), the authors concluded
that the study population in research on the prevalence of
multimorbidity required special attention. Their study,
however, was limited to people ≥ 55 years of age, and the
diseases considered for prevalence estimates of multi-
morbidity varied in the different study populations. Fur-
thermore, information about all morbidities (complaints,
diseases and disorders) was collected from medical charts
for patients in general practice and from a limited list of
chronic conditions for the general population [4]. We
believe that differences among the diagnoses considered
could have influenced estimates of the prevalence of mul-
timorbidity. Analysis of how the prevalence of multimor-
bidity in the general population is reflected in clinical
practice has not yet been done. To make a valid compari-
son of prevalence estimates, data should be obtained
simultaneously or within a short time frame from both
general and primary care populations. In addition, the
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medical conditions taken into account and the opera-
tional definition of multimorbidity used should be consis-
tent. Data from the general population, although useful
for a comparison of different geographical areas, provide
an incomplete picture of where chronic diseases are dealt
with, for example, in the offices of family doctors.
A recent publication [14] in which prevalence estimates
of multimorbidity were calculated using data obtained in
2005 from the general population of the province of Que-
bec, Canada, allowed us to make a comparison with prev-
alence estimates of multimorbidity using data from a
2003 family practice-based study [13] in the same prov-
ince. The aim of the current study was to compare age-
and sex-specific estimates of the prevalence of multimor-
bidity derived from these two populations, and to exam-
ine the impact of a variation in the number of different
diagnoses considered on prevalence estimates within the
practice-based population.
Methods
The prevalence of multimorbidity in the general popula-
tion of Quebec comes from a Quebec publication [14]
based on data from the Canadian Community Health
Survey (CCHS). The CCHS is a series of general surveys
that Statistics Canada http://www.statcan.gc.ca has car-
ried out since 2000. Approximately 132,000 randomly-
selected Canadians (26,000 from Quebec) 12 years and
older participate, either in person or by telephone, in a
45-minute computer-assisted interview. For the current
study, we used data collected in the 2005 CCHS [14] on
the self-reported presence of seven diseases: arthritis,
cancer, diabetes mellitus, hypertension, heart disease,
obstructive lung disease and psychiatric problems. We
limited calculations to results from participants aged 25
years and over to permit comparisons.
W e obtained family practice-based data from a study
conducted by our research group in the Saguenay region
of Quebec in 2003 [13]. In this study, trained research
staff extracted diagnoses of chronic diseases from
patients' medical charts. Details of the methods and sam-
pling strategies used in this study are described elsewhere
[13]. The regional ethics committee approved the original
Saguenay study. In brief, 980 (90%) of 1085 consecutive
adult patients solicited during successive consultation
periods from 21 family physicians' practices consented to
participate.
For the current study, we limited chronic diseases to the
same seven diseases included in the CCHS. We also cal-
culated estimates of the prevalence of multimorbidity in
the family-practice patients with an open list of chronic
diseases, i.e., all the diseases that might have appeared in
the patients' medical records.
We retained the two operational definitions of multi-
morbidity used in the CCHS report [14]; that is, we
defined multimorbidity as (1) ≥ 2 diseases and (2) ≥ 3 dis-
eases. Both definitions were previously used in several
other studies [13-17]. Disease complications were consid-
ered as distinct diseases. For the comparison of preva-
lence data between the two studies [13,14], we compared
multimorbidity data for participants ≥ 25 years of age
only because these data were available from both the
Saguenay [13] and the CCHS [14] studies. Subjects were
grouped by age as follows: 25-44 yr, 45-64 yr, 65-79 yr,
and 80 yr and over. The analysis was done at the patient
level only, as clustering of patients by physician in the
Saguenay study was negligible.
We estimated age-specific and sex-specific prevalence,
without adjustment for the cluster sample study design
and subsequently calculated age-standardized prevalence
using the general population as a reference. To determine
the significance of different prevalence estimates we cal-
culated Fisher's 95% confidence intervals looking for
overlap and also compared them graphically.
Table 1: Demographic information
No. (%)
Group Estimated population of Quebec
(N = 6,447,800)
Saguenay family practice-based sample
(N = 938)
Males* 3,171,500 (49.2) 315 (33.6)
Females* 3,276,300 (50.8) 623 (66.4)
25-44 y 2,147,800 (33.3) 179 (19.1)
45-64 y 2,088,100 (32.4) 407 (43.4)
65-79 y 771,700 (12.0) 239 (25.5)
≥80 y 187,200 (2.9) 52 (5.5)
*Age of Quebec estimated population: ≥12 years; age of Saguenay sample: ≥25 years.Fortin et al. BMC Health Services Research 2010, 10:111
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Results
Table 1 shows demographic information for the two sam-
ples. Because the age distribution of the two populations
was different, age-specific analyses of multimorbidity
were done. Because age distribution by sex was not avail-
able from the CCHS, the sex distributions included data
from subjects ≥ 12 years of age in the general population
and subjects ≥ 25 years of age in the family practice-based
population. Compared with the general population, the
prevalence of ≥ 2 chronic diseases in the family practice-
based population was 5.0 times higher in men and 3.5
times higher in women; prevalence of ≥ 3 diseases was 9.0
times and 4.5 times higher, respectively. More women
than men were found with multimorbidity in the general
population, whereas the reverse was found in the prac-
tice-based population. In the general population, 10.1%
(95% confidence interval [CI]: 10.0-10.1) of men and
13.3% (CI: 13.2-13.3) of women had ≥ 2 diseases; in the
practice-based population, results were 51.9% (CI: 46.3-
57.5) of men and 46.1% (CI: 42.2-46.1) of women. The
proportion of men with ≥ 3 diseases in the general popu-
lation was 3.4% (CI: 3.38-3.42); the proportion of women
was 4.5% (CI: 4.4-4.5). The proportions were 30.9% (CI:
25.9-36.3) of men and 20.2% (CI: 17.2-23.4) of women in
the practice-based population. Note that no confidence
intervals overlap. Because analyses by sex for specific age
groups were not provided for the general population
study, we did not calculate age- and sex-standardized
rates for the family practice-based population.
The age-specific overall prevalence of ≥ 2 diseases for
both study populations is shown in Figure 1. The preva-
lence in each age group is substantially higher in the prac-
tice-based than in the general population. Also, the rates
of increase in the prevalence of morbidity (≥ 2 diseases)
with age differed between the two study populations
(approximately 1.3%/yr in the practice-based, and 0.8%/yr
in the general population). The age-standardized preva-
lence of ≥ 2 diseases (25 yr and over; reference: general
population) was 32.3% in the practice-based and 11.6% in
the general population: a 2.8:1 ratio.
In Figure 2, the age-specific overall prevalence of ≥ 3
diseases for both study populations is shown. As with the
previous operational definition, the prevalence in each
age group is substantially higher in the practice-based
than in the general population and the differential in the
annualized increase in the prevalence of ≥ 3 was even
more pronounced than for ≥ 2 diseases: 1.1%/yr vs. 0.3%/
yr. The age standardized prevalence of ≥ 3 diseases (25 yr
and over; reference: general population) was 14.0% in the
practice-based population and 3.9% in the general popu-
lation: a 3.6:1 ratio.
Figure 3 compares prevalence estimates of multimor-
bidity (defined as ≥ 2 diseases) based on the list of seven
conditions with those based on an open list of chronic
diseases for the family practice-based group of patients.
Differences were marked, especially for younger age
groups. Multimorbidity prevalence estimates for the 25-
44 year group were 17.1% when based on the list of seven
conditions, and 73.9% when based on an open list of
chronic diseases in the practice-based group. For the 45-
64 year group, prevalence estimates were of 47.3% and
93.1%, respectively.
Discussion
Results of the current study suggest that estimates of the
prevalence of multimorbidity based on a simple count of
diseases for the general population are not equivalent to
those for family practice-based populations. Sex- and
Figure 1 Age-specific prevalence of multimorbidity and 95% 
confidence intervals (error bars) for those with ≥ 2 diseases.
Figure 2 Age-specific prevalence of multimorbidity and 95% 
confidence intervals (error bars) for those with ≥ 3 diseases.Fortin et al. BMC Health Services Research 2010, 10:111
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age-specific prevalence estimates of multimorbidity as
well as age-standardized prevalence estimates are sub-
stantially higher in the family practice-based than in the
general population. The nature of the study population is,
therefore, a major factor in the accurate interpretation of
studies of the prevalence of multimorbidity. In the cur-
rent study, for patients with ≥ 2 chronic diseases -- the
classical definition of multimorbidity -- the difference in
prevalence estimates of multimorbidity for the family
practice-based and general care studies reached 40%.
Based on age-standardized estimates, the prevalence was
approximately three times higher for the primary care-
based population. Differences were even more marked
for patients with ≥ 3 chronic diseases.
Prevalence estimates of multimorbidity in the general
population are important for reporting about the health
status of the population. However, the results of the cur-
rent study suggest that the clinical burden of multimor-
bidity is higher in family practice than would be expected
from data collected for the general population, highlight-
ing the importance of having prevalence estimates at the
practice level, and the development and implementation
of practice-based epidemiological research. Because of
the large percentage of patients with multimorbidity,
including geriatric patients, in the primary care popula-
tion, primary care settings must be strengthened quanti-
tatively and qualitatively to keep pace with this growing
problem.
The operational definition considered in prevalence
studies about multimorbidity is the second most impor-
tant concern. In the current study, we found that the
greater the number of diagnoses included, the higher the
prevalence estimates of multimorbidity. Using the same
classical definition of multimorbidity and the same age
groups, but varying the number of diagnoses considered
(a list of 7 conditions vs. an open list) to compare preva-
lence estimates for the same family practice-based popu-
lation, we found large differences in these estimates
across all age groups (Fig. 3).
Moreover, not only the number of diseases, but also the
way they are documented is important. Prevalence esti-
mates of multimorbidity calculated with a different defi-
nition in a Netherlands study [2] were well below those of
the current study calculated with an open list of diagno-
ses. The Netherlands study [2] analyzed data from a data-
base of 60,857 patients from a registration network of
family practices in the Netherlands [2] to estimate the
prevalence of the co-occurrence of ≥ 2 "active health
problems". Health problems, based on ICPC codes
related to rubrics, were defined as "active" if identified by
the general practitioner or the patient, as reflected in cur-
rent treatment, subsequent diagnostic investigations, dis-
ease monitoring, or the known progressive course of a
disease. Prevalence of the co-occurrence of ≥ 2 active
health problems for patients 20-39 years of age was 16.0%
for men and 18.8% for women; for those 40-59 years of
age, 33.6% for men and 35.9% for women; for those 60-79
years of age, 60.9% for men and 64.9% for women; for
those ≥ 80 years of age 74.2% for men and 79.9% for
women. Compared with the study in Saguenay, these dif-
ferent results may represent real differences in the preva-
lence of multimorbidity or may be the consequence, at
least in part, of the way the diseases were documented in
each study. Sampling also contributes to the difference.
The Saguenay study recruited patients attending the
practice. This could bring out a higher proportion of
patients with complex needs as they consult more often
and therefore have a higher chance of being selected. At
the same time, this provides us with a good estimate of
the burden at the practice level. On the other hand, the
Netherlands study included all patients from the register
(including those consulting less often). This could explain
part of the difference. Furthermore, including complica-
tions of previous conditions could result in a higher count
of diseases. For example, diabetes complicated by renal
failure and neuropathy would have counted as three sepa-
rate occurrences in the Saguenay study thus contributing
to the higher numbers.
Many prevalence studies use a limited list of chronic
conditions [4,6,7,9,11,12]; however, not including fre-
quent conditions could affect prevalence results. Simi-
larly, the inclusion of medical conditions considered as
risk factors is controversial. For example, hyperlipidemia
and obesity are two common conditions frequently omit-
ted from prevalence studies [4,6,12]. The real require-
ment for medical treatment of such conditions makes a
strong argument for their inclusion in the count. Limiting
Figure 3 Prevalence of multimorbidity (as defined by the pres-
ence of ≥ 2 diseases) and 95% confidence intervals (error bars) es-
timated with a list of seven diseases and with an open list.Fortin et al. BMC Health Services Research 2010, 10:111
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the number of diagnoses considered when defining mul-
timorbidity is of special concern because of the great het-
erogeneity in disease burden observed among patients
with chronic conditions. Ideally, studies about the preva-
lence of multimorbidity should be based on a standard
list of chronic conditions that include at a minimum the
most frequent diagnoses. From their review of the litera-
ture, Bayliss and colleagues [18] compiled a list of 24
health conditions most frequently assessed for the mea-
surement of co-morbidity to develop an instrument for
the assessment of disease burden. Such a list could be a
good reference point for estimating the prevalence of
multimorbidity in different populations. If the Interna-
tional Classification of Primary Care-Version 2 (ICPC-2)
is used, a good reference point for estimating the preva-
lence of multimorbidity could be the list of chronic condi-
tions designed by O'Halloran and colleagues[19], based
on the ICPC-2 (list available at http://www.fmrc.org.au/
Download/DefiningChronicConditions.pdf). The list,
although designed to identify chronic conditions man-
aged in Australian general practice, could be used in
other settings.
According to the present study, in the general popula-
tion, there were more women than men with multimor-
bidity, but more men than women with multimorbidity
are seen in primary care. In the general practice popula-
tion, prevalence rates tend to be higher among men in the
younger age groups [13]. Differences in the severity of
disease may lead to a different pattern of consultation or
to differences in the timing of seeking medical attention
[20]. In general, other population-based studies [5,6,9]
have shown a higher prevalence of multimorbidity in
women. For general practice, some studies [2,3] reported
an age-specific prevalence that tended to be higher for
younger men and higher for older women. Another study
[7] reported no difference in the prevalence of multiple
diseases between sexes in general practice. However, dis-
eases were classified according to the Cumulative Illness
Rating Scale (CIRS) morbidity domains and multimor-
bidity was defined as presence of morbidity in two or
more domains rather than individual diseases. It could
have contributed to the lack of differences among gender
groups as diseases within the same CIRS domain would
count only for one.
The strength of the current study lies in its comparison
of two different sources of data that were collected within
a relatively short time span, thus validating the compari-
son. When we look at the relatively slow rate of the inci-
dence of chronic diseases and their long duration, the
difference of two years between the two studies' data col-
lections seems negligible for the comparison of two dif-
ferent populations.
This study has limitations. The comparison of preva-
lence estimates by sex was limited by the different age
spans of the study populations (Table 1). Prevalence esti-
mates in the current study may have been affected by the
different methods of collecting the data in the two studies
compared. Another limitation is that we estimated age-
specific and sex-specific prevalence without adjustment
for the cluster sample study design, however, it is unlikely
that this has affected the findings in terms of the differ-
ences in results from the two methods because of the
large differences found. In the 2005 study, trained
research staff extracted diagnoses of medical conditions
from patients' medical charts, making its data collection
different from the self-report method used in the CCHS.
Because several studies [21-25] have suggested that self-
reported and record-based estimations of multimorbidity
provide similar results, we considered that a comparison
between these two studies was valid. However, other
studies [26-28] have reported differences. The question-
naire used for the general population group is susceptible
to a self-declaration bias; patients may underreport diag-
n o s e s  o f  l e s s  i m p o r t a n c e  t o  t h e m  o r  t h a t  t h ey  d o  n o t
recall [27]. However, with the exception of psychiatric
diseases, questions about the presence of diseases were
specific in the CCHS [14] and facilitated recall. Con-
versely, using medical records alone may result in an
underestimation of some symptom-based conditions
[26]. The direction of the bias with different sources of
data could go either way. However, any bias that might
have been introduced in the current study is unlikely to
affect the robustness of the conclusions, given the magni-
tude of the most important differences.
Conclusions
Prevalence estimates of multimorbidity for the family
practice-based population were higher than those for the
general population, in both men and women. Age-spe-
cific prevalence estimates were also higher for all age
groups in the family practice population and had a higher
rate of increase with age. Based on age-standardized esti-
mates and a classical definition of multimorbidity, the
prevalence in the practice-based population was three
times higher. When the number of chronic conditions
considered increased, the prevalence estimate of multi-
morbidity was higher. The use of a limited list of chronic
diseases may introduce an important bias in the preva-
lence estimates of multimorbidity. Reporting prevalence
estimates should always specify the reference population,
the method of estimation, and the data source to allow
comparison and accurate interpretation of prevalence
studies about multimorbidity. The clinical burden on
family practice was higher than expected from the data
collected for the general population, highlighting the
importance of prevalence estimates of multimorbidity at
the practice level.Fortin et al. BMC Health Services Research 2010, 10:111
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